Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma.
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
S
S
Dietrich
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
J
J
Weidle
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
M
M
Rieger
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
J
J
Meissner
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
A
A
Radujkovic
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
A D
AD
Ho
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
P
P
Dreger
Department of Hematology, University Hospital of Heidelberg, Heidelberg, Germany.
M
M
Witzens-Harig
D000328:Adult; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D033581:Stem Cell Transplantation
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab